Characterization of Immune Checkpoint Inhibitor-Related Cardiotoxicity in Lung Cancer Patients From a Rural Setting

Characterization of Immune Checkpoint Inhibitor-Related Cardiotoxicity in Lung Cancer Patients From a Rural Setting

Background: Immune checkpoint inhibitor (ICI)-related cardiotoxicity (iRC) is uncommon but can be fatal. There have been few reports of iRC from a rural cancer population and few data for iRC and inflammatory biomarkers. Objectives: The purpose of this study was to characterize major adverse cardiac...

Full description

Bibliographic Details
Main Authors: Melissa Y.Y. Moey, MD, MSc, Anna N. Tomdio, MD, Justin D. McCallen, BSc, Lauren M. Vaughan, MD, Kevin O’Brien, PhD, Abdul R. Naqash, MD, Cynthia Cherry, RN, ANP, Paul R. Walker, MD, Blase A. Carabello, MD
Format: Article
Language:English
Published: Elsevier 2020-09-01
Series:JACC. CardioOncology
Subjects:
immune checkpoint inhibitors
inflammatory markers
myocarditis
neutrophil-to-lymphocyte ratio
Online Access:http://www.sciencedirect.com/science/article/pii/S2666087320301678

Similar Items

Similar Items